HTG Molecular Diagnostics, Inc. (HTGMQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | 6.36 Million USD | -28.52% |
| 2021 | 8.9 Million USD | 4.19% |
| 2020 | 8.54 Million USD | -55.48% |
| 2019 | 19.2 Million USD | -10.7% |
| 2018 | 21.5 Million USD | 45.69% |
| 2017 | 14.75 Million USD | 187.56% |
| 2016 | 5.13 Million USD | 27.0% |
| 2015 | 4.04 Million USD | 21.41% |
| 2014 | 3.32 Million USD | 48.41% |
| 2013 | 2.24 Million USD | -9.58% |
| 2012 | 2.48 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q2 | - USD | -100.0% |
| 2023 Q1 | 1.03 Million USD | -57.67% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q4 | 2.43 Million USD | 95.01% |
| 2022 Q2 | 1.49 Million USD | 25.93% |
| 2022 Q1 | 1.18 Million USD | -58.83% |
| 2022 Q3 | 1.25 Million USD | -16.14% |
| 2022 FY | 6.36 Million USD | -28.52% |
| 2021 Q2 | 2.07 Million USD | 44.53% |
| 2021 Q3 | 2.52 Million USD | 21.51% |
| 2021 FY | 8.9 Million USD | 4.19% |
| 2021 Q4 | 2.87 Million USD | 14.15% |
| 2021 Q1 | 1.43 Million USD | -44.44% |
| 2020 Q4 | 2.58 Million USD | 45.35% |
| 2020 Q3 | 1.77 Million USD | -9.48% |
| 2020 Q2 | 1.96 Million USD | -11.78% |
| 2020 Q1 | 2.22 Million USD | -53.64% |
| 2020 FY | 8.54 Million USD | -55.48% |
| 2019 FY | 19.2 Million USD | -10.7% |
| 2019 Q4 | 4.79 Million USD | -11.19% |
| 2019 Q3 | 5.4 Million USD | -6.75% |
| 2019 Q2 | 5.79 Million USD | 80.98% |
| 2019 Q1 | 3.2 Million USD | -58.56% |
| 2018 FY | 21.5 Million USD | 45.69% |
| 2018 Q4 | 7.72 Million USD | 64.2% |
| 2018 Q1 | 4.15 Million USD | -47.39% |
| 2018 Q2 | 4.91 Million USD | 18.09% |
| 2018 Q3 | 4.7 Million USD | -4.16% |
| 2017 Q4 | 7.9 Million USD | 112.28% |
| 2017 FY | 14.75 Million USD | 187.56% |
| 2017 Q1 | 1.37 Million USD | -5.94% |
| 2017 Q2 | 1.76 Million USD | 28.41% |
| 2017 Q3 | 3.72 Million USD | 111.47% |
| 2016 Q3 | 913.9 Thousand USD | -51.79% |
| 2016 Q2 | 1.89 Million USD | 119.11% |
| 2016 Q1 | 865.23 Thousand USD | -28.83% |
| 2016 FY | 5.13 Million USD | 27.0% |
| 2016 Q4 | 1.45 Million USD | 59.51% |
| 2015 FY | 4.04 Million USD | 21.41% |
| 2015 Q1 | 1.02 Million USD | -21.07% |
| 2015 Q4 | 1.21 Million USD | 20.26% |
| 2015 Q3 | 1.01 Million USD | 27.88% |
| 2015 Q2 | 790.55 Thousand USD | -22.82% |
| 2014 FY | 3.32 Million USD | 48.41% |
| 2014 Q3 | 870.24 Thousand USD | 160.26% |
| 2014 Q2 | 334.37 Thousand USD | -59.54% |
| 2014 Q1 | 826.52 Thousand USD | 34.61% |
| 2014 Q4 | 1.29 Million USD | 49.13% |
| 2013 Q4 | 613.99 Thousand USD | 19.5% |
| 2013 FY | 2.24 Million USD | -9.58% |
| 2013 Q2 | 557.63 Thousand USD | 0.0% |
| 2013 Q3 | 513.82 Thousand USD | -7.86% |
| 2012 FY | 2.48 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -597.286% |
| Arrayit Corporation | 4.37 Million USD | -45.437% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 75.38% |
| Bioqual, Inc. | 58.59 Million USD | 89.134% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 58.38% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.914% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -505.39% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 84.169% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -1322.622% |
| InVitro International | 792.62 Thousand USD | -703.179% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 42.806% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | 11.877% |
| NovelStem International Corp. | 12 Thousand USD | -52951.833% |
| Optigenex Inc. | 465.97 Thousand USD | -1266.23% |
| PharmChem, Inc. | 6.01 Million USD | -5.885% |
| Proteome Sciences plc | 6.4 Million USD | 0.538% |
| Response Genetics, Inc | 18.04 Million USD | 64.711% |
| Rennova Health, Inc. | 13.03 Million USD | 51.165% |
| RushNet, Inc. | 1.78 Million USD | -256.076% |
| ScreenPro Security Inc. | 1.91 Million USD | -232.595% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -67.749% |
| Todos Medical Ltd. | 7.69 Million USD | 17.268% |